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FY Infections per 1000 Line Days
2005 5.45
2006 6.35
2007 4.83
2008 4.31
2009 1.98
2010 1.68
2011 0.64
2012 .88
Annual Cumulative 0.61 (9/11-8/12)
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and reducing costs are crucial goals in today's healthcare
environment. Our busy inpatient unit with a full census was
leading to the overnight stays for mobilization chemo-
therapy taking lower priority than admissions for transplant
and readmissions. Mobilization chemotherapy patients were
being postponed and rescheduled to later dates and times
due to a lack of inpatient beds. The constant full census and
projected growth of our BMT program required a permanent
solution.
Purpose: The goal of this project was to determine if cyclo-
phosphamide used for mobilization could safely be admin-
istered in the outpatient setting.
Interventions: A multidisciplinary team including home
pharmacy, nursing staff, ﬁnancial coordinators, CNS and
physicians gathered to brainstorm ideas to address bed
utilization. Shifting cyclophosphamide mobilization to the
outpatient setting appeared to be a viable solution. The
potential risks and beneﬁts of this practice shift were
explored. Physician orders were modiﬁed and educationwas
provided to the outpatient nurses. A date for go live was set
for a three month trial period.
Evaluation: The inpatient night shift nurse phoned patients
on the evening of cyclophosphamide administration to
assess symptoms and symptom management. Patients
completed a symptom experience survey at 24 and 48 hours
post cyclophosphamide administration.
Discussion: Cyclophosphamide for mobilization may be
given safely as an outpatient. To crucial goals of reducing
costs and improving inpatient bed utilization were achieved.507
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Healthcare reform is nationally charging patient safety
initiatives including eliminating catheter associated blood
stream infections (CA-BSI). Historically, a mid-west pediatric
institution's highest CA-BSI rates resided on the Bone
Marrow Transplant (BMT) Unit housing the most severely
immune compromised patients. The complex 24 bed critical
care unit performs over 90 transplants annually with over
70% being allogeneic. In 2006, BMT's CA-BSI rates reached
a high of 6.35 infections per 1,000 catheter days.
Initially, a CA-BSI maintenance bundle developed in the
intensive care unit was introduced. During the ﬁrst year,
a 32% CA-BSI rate reduction occurred.
A multidisciplinary approach utilizing quality improve-
ment methodology was implemented. Key drivers, condi-
tions creating the ideal state for project success, were
established and guided subsequent interventions via a Plan,
Do, Study, Act model. Ongoing interventions addressed
unique challenges of a highly immune compromised pop-
ulation leading to the “Supercharged Maintenance Bundle.”
formation. Over the next two years, an additional 60% rate
reduction was realized leading to a 1.98 infection rate.
Further interventions generated by a national pediatric
immune compromised patient focused collaborative resulted
in 0.64 infections for FY11, an additional 50% two year
decline.
FY12 resulted in an increased rate of 0.88 infections
further challenging the quest to sustain gains and eliminateCA-BSI. Continued multidisciplinary approaches focusing on
high reliability concepts are essential to sustainability.
Speciﬁcally, preoccupation with failure accompanied by an
in-depth infection analysis providing lessons learned help
continually generate heightened awareness to those identi-
ﬁed risk factors and associated preventative strategies. These
actions lead by the bedside nurse, fuel the awareness and
commitment of all caring for a highly complex and vulner-
able patient population leading to the current 0.61 infections
rate.508
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Objective: A comprehensive understanding on the part of
the patient undergoing an HPCT and caregiver regarding the
experience during the hospitalization and the follow up care
required.
Background: The process of HPCT can be a complex and
confusing experience for a patient and their caregivers.
Education is often provided in a single session when trans-
plant is the chosen treatment. These sessions can be over-
whelming and therefore much of the information is not
always retained.
Purpose: To decrease feelings of anxiety and increase
compliance by the HPCT patient in order to maintain his/her
well being during the continuum of care.
Interventions: At NYU Langone Medical Center, the patient
is given an educational document titled “Going Home After
Stem Cell Transplant” by the Registered Nurse (RN) at the
clinical cancer center. In collaboration with the outpatient
RN, the inpatient RN continues utilizing this document once
the patient is admitted. Throughout the hospitalization
ample time is allotted with each patient and caregiver to
discuss discharge plans. The admitting inpatient RN assesses
several factors that may inﬂuence learning including
language, literacy, willingness, and emotional well-being.
Patients are continuously instructed at their own pace on
topics pertaining to their disease process and lifestyle
changes. Teaching techniques are individualized to patients
and caregivers and include printed materials, verbal
instruction and return demonstrations. The RN instructs the
patient and caregiver to refer to the post-HPCT discharge
document frequently and encourages them to ask questions
as they arise.
Evaluation: Evaluation of the seamless education process is
currently being conducted by reviewing patient satisfaction
scores speciﬁc to patient education. Patients provide
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cancer center through questions, answers and informal
discussions.
Discussion: Patient and family education by nursing plays
a key role in the experience of the HPCT patient, in both the
inpatient and outpatient settings. Continuous education
allows the patient to feel conﬁdent and knowledgeable on
his/her disease and transplant. These teaching strategies
allow the patient to take control of his/her care, increase
safety and satisfaction while decreasing anxiety.509
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The adult bone marrow transplant unit of this NCI
designated comprehensive cancer center performed change
of shift report with an electronic nursing hand off and face to
face reporting. In an effort to improve communication,
positively impact patient satisfaction, decrease intershift call
bell interruptions, provide an opportunity for peer review,
and reinforce patient safety guidelines we have imple-
mented bedside walking rounds.
Walking rounds were implemented as an enhancement
to the existing nursing handoff process. We believe it
provides an opportunity for the patient to participate in their
plan of care increasing feelings of personal empowerment,
improves communication between nurses, provides a clini-
cally relevant opportunity for 2 nurses to perform patient
identiﬁcation, and permits the daily re-enforcement of
patient safety guidelines enhancing patient's feelings of
safety and security.
Staff was educated regarding the beneﬁts of walking
rounds, staff suggestions were solicited for clinically relevant
assessments to be performed during walking rounds and to
create buy in for project implementation. Walking rounds
now occur in the patient's room at shift change with an
opportunity for patient input and the potential for early
assessment of acute changes in patient's condition.
Data was collected prior to and after the implementation
of walking rounds categorizing the frequency of shift
change interruption and the reasons for patient calls. The
data supports a decrease in the frequency of patient calls
during shift change since the program's implementation.
Anecdotal evidence, from patients reporting, suggests
increased patient satisfaction related to decreases in call
bell response time.
Walking rounds has been a beneﬁcial enhancement to
patient handoff, improving communication, empowering
patients, decreasing shift change interruptions, decreasing
call bell response time, and improving patient's and
nurse's satisfaction by enabling a safe professional transfer
of care.510
Decreasing Readmission Rates in Autologous Stem Cell
Transplant Patient for Symptom Management
Gina Green 1, Kelly Cherni 1, Christina Ferraro 2,
Matt E. Kalaycio 3, Sheila Seraﬁno 4. 1 Bone Marrow Transplant,
Cleveland Clinic, Cleveland, OH; 2 Bone Marrow Transplant, TheCleveland Clinic, Cleveland, OH; 3 BMT Program, Cleveland
Clinic Foundation, Cleveland, OH; 4 BMT, Cleveland Clinic,
Cleveland, OH
As of July 7th 2011, in an effort to decrease readmission
rates, the Bone Marrow Transplant (BMT) program instituted
a requirement for all autologous stem cell transplant patients
to be seen at the Taussig Cancer Center within 2-4 days
following discharge for symptom assessment and labs. Prior
to this change, patients had labs done locally and were
contacted by their nurse coordinator within 48 hours of
discharge. Patients were seen for symptom assessment by
their local oncologist within one week.
Data review for 6/2010 e 6/2011 found there were a total
of 142 patients discharged and 11 readmissions within the
ﬁrst 30 days of discharge; 4, or 36% of those were for
symptom control, which included pain management, short-
ness of breath (SOB), and nausea, vomiting, and diarrhea
(N/V/D).
Prior to discharge, patients and their caregivers are
educated about post-transplant care. Medications for
symptom management, usually prescribed ‘as needed’ are
often misunderstood. In an effort to provide clarity we
instituted:
 A ‘Med Action’ form, created by the PharmD, with the
generic and brand names of each medication, dosage,
frequency, and rationale
 The PharmD reviews the ‘Med Action’ form the
morning of discharge
 Patients discharged on blood pressure (BP) medications
are instructed on the use of a BP monitor, and logging
their readings twice a day
At the follow-up visits, the BMT nurse assesses patient's
symptom control and understanding of their discharge
instructions, including medications. It was found that:
i 53% were dehydrated, (evidenced by orthostatic vital
signs), requiring IV ﬂuids
ii 37% required a medication change
iii 39% needed additional appointments for symptom
management
Between 7/2011 and 7/2012, out of 129 patients, 11 were
readmitted, 2 for symptom control.
Conclusions:
 Outpatient visits for symptom assessment/intervention
were effective in preventing readmissions for symptom
management
 The 2 patients readmitted for symptom management
had Primary Amyloidosis. They were found to have EGD
biopsy proven Amyloidosis of the gut diagnosed post
transplant. This may have contributed to the long
term intensive pharmacological/medical management
needed for nausea and vomiting.
 Readmission rates overall increased by 0.8%, however
only 9% were for symptom management. The remain-
ing 91%, readmitted per BMT program protocol, were
for infections and fevers.511
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